| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 01/18/1994 | US5279823 Purified forms of DNASE |
| 01/18/1994 | US5279812 Radiolabeled anticoagulant peptides |
| 01/12/1994 | EP0578472A2 A process for recovering peptides expressed as fusion proteins |
| 01/12/1994 | EP0578356A2 Mycoplasma protein promoting metastases and antibody against it |
| 01/12/1994 | EP0578342A2 Purification and characterization of a CSVTCG-specific tumor cell adhesion receptor |
| 01/12/1994 | EP0578145A1 Compounds and process for photoactivable labelling of biomolecules |
| 01/12/1994 | EP0577752A1 Human pf4a receptors and their use |
| 01/12/1994 | EP0577605A1 G protein-coupled glutamate receptors |
| 01/12/1994 | EP0423228B1 Immunoconjugates for cancer diagnosis and therapy |
| 01/12/1994 | EP0419509B1 Conductance measurements in organic solvents |
| 01/12/1994 | EP0365654B1 Elastomeric polypeptides as vascular prosthetic materials |
| 01/11/1994 | US5278288 Contacting milk raw materials containing the glycomacropeptide with cation exchanger to adsorb a fraction of the material, collecting a nonadsorbed fraction, concentrating and desalting the fraction |
| 01/11/1994 | US5278286 Polypeptides |
| 01/11/1994 | US5278284 Protein purification method |
| 01/11/1994 | US5277908 Modified superoxide dismutase |
| 01/11/1994 | US5277893 Direct radiolabeling of substrates containing monosulfides or disulfide bonds with radionuclides |
| 01/11/1994 | CA1326107C Heterocyclic ketones |
| 01/11/1994 | CA1326106C Production of proteins in active forms |
| 01/08/1994 | CA2099967A1 Process for recovering peptides expressed as fusion proteins |
| 01/06/1994 | WO1994000596A1 Acceptor for fucosyltransferase |
| 01/06/1994 | WO1994000557A1 Method for preparing membrane proteins and preserving their oligomeric structures under denaturing conditions, and uses of said proteins in diagnostics and vaccination |
| 01/06/1994 | WO1994000509A1 Oxazolone derived materials |
| 01/06/1994 | WO1994000489A2 Radioactively-labeled somatostantin-derived peptides for imaging and therapeutic uses |
| 01/06/1994 | WO1994000485A1 Multimeric forms of human rhinovirus receptor protein |
| 01/06/1994 | WO1994000483A1 PURIFICATION OF KRINGLE CONTAINING PROTEINS, AND ESPECIALLY t-PA |
| 01/06/1994 | WO1994000482A1 Isolation and characterization of the growth hormone releasing hormone receptor |
| 01/06/1994 | WO1994000481A1 Pharmaceutical composition containing botulinum b complex |
| 01/06/1994 | WO1994000464A1 Deproteinization with azlactone-functional supports |
| 01/06/1994 | WO1994000213A1 Method for purifying hydrophobic proteins and peptides by means of hydrophobic zeolites |
| 01/06/1994 | WO1994000151A1 Combinatorial polypeptide antigens |
| 01/06/1994 | CA2139350A1 Oxazolone derived materials |
| 01/06/1994 | CA2137779A1 Purification of kringle containing proteins, and especially t-pa |
| 01/06/1994 | CA2137008A1 Acceptor for fucosyltransferase |
| 01/06/1994 | CA2136432A1 Deproteinization with azlactone-functional supports |
| 01/06/1994 | CA2116109A1 Multimeric forms of human rhinovirus receptor protein |
| 01/05/1994 | EP0577565A2 Stabilized compositions of the delta antigen peptide of hepatitis D virus |
| 01/05/1994 | EP0577544A1 Novel cyclosporins having modifications at position 1 |
| 01/05/1994 | EP0577243A2 Recombinant human HIV-neutralizing monoclonal antibodies for prevention and treatment of HIV infection |
| 01/05/1994 | EP0576988A1 Isolation and characterization of the growth hormone releasing hormone receptor |
| 01/05/1994 | EP0576589A1 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 01/05/1994 | EP0576562A1 Lipid fractionation |
| 01/05/1994 | EP0396733B1 Improved extraction methods for preparing thromboplastin reagents |
| 01/04/1994 | US5276142 Vaccines |
| 01/04/1994 | US5276141 Adding divalent metal ion to culture product to form a mixture which precipitates, harvesting said protein |
| 01/04/1994 | US5276062 HPLC avidin monomer affinity resin |
| 01/04/1994 | US5276013 Conjugates of biologically stable polyfunctional molecules and polynucleotides for treating systemic lupus erythematosus |
| 01/04/1994 | US5275941 Process for the preparation of N-protected dialkyl (2S,3S)-3-ethylaspartates |
| 01/04/1994 | US5275838 Immobilized polyethylene oxide star molecules for bioapplications |
| 12/29/1993 | EP0576095A1 Immunoassays with labeled thyronine hapten analogues |
| 12/29/1993 | EP0575779A1 Crotonic acid phenacylesters and their use as linkers |
| 12/29/1993 | EP0575545A1 Pegylation of polypeptides |
| 12/29/1993 | EP0575517A1 Lipid a analog/immunogenic carrier conjugates, the use thereof as vaccines and polyvalent hyperimmune gammaglobulins |
| 12/29/1993 | EP0575491A1 Genetically engineered vaccine strain |
| 12/29/1993 | EP0575490A1 GnRH ANALOGS |
| 12/29/1993 | EP0575485A1 Process for the development of binding mini-proteins |
| 12/29/1993 | EP0575463A1 C-terminal peptide sequencing using diphenyl phosphoroisothiocyanatidate and pyridine |
| 12/29/1993 | EP0575432A1 Modified proteins and their use for controlling viral infections |
| 12/29/1993 | EP0575311A1 Control of secretion of milk |
| 12/29/1993 | EP0538398A4 Tissue-derived tumor growth inhibitors, methods for preparation and uses thereof |
| 12/29/1993 | EP0516729B1 N-phenyl n-alkoxycarbonylalkyl glycinamides, preparation method and drugs containing them |
| 12/29/1993 | EP0454739B1 Method of recovering purified epi protein from a solution especially a fermentation solution |
| 12/29/1993 | EP0365597B1 Improved processes for the treatment of vascular disease |
| 12/29/1993 | EP0192671B1 Minactivin |
| 12/28/1993 | US5273966 Having two mannose residues attached to the threonine (29) amino acid |
| 12/28/1993 | US5273960 High purity crystalline peptides arglysasp and arglysaspval and a process for their preparation |
| 12/28/1993 | US5273715 Automated system for providing a sequence of chemicals to a reaction process |
| 12/28/1993 | US5273656 System for solid phase reactions |
| 12/28/1993 | CA1325695C Peptides with pharmaceutical activity |
| 12/23/1993 | WO1993025688A1 Recombinant production of saporin-containing proteins |
| 12/23/1993 | WO1993025681A1 A cytoplasmic chaperonin and methods of making and using it |
| 12/23/1993 | WO1993025670A1 Purified forms of dnase |
| 12/23/1993 | WO1993025637A1 Biocatalytic desulfurization of organosulfur molecules |
| 12/23/1993 | WO1993025579A1 Glucagon-like peptide and insulinotropin derivatives |
| 12/23/1993 | WO1993025577A2 Active component of parathyroid hypertensive factor |
| 12/23/1993 | WO1993025572A1 T-cell monocyte inducing proteins (tmips) |
| 12/23/1993 | WO1993025571A1 Liquid phase synthesis of peptides and peptide derivatives |
| 12/23/1993 | WO1993025247A1 Immobilized polyethylene oxide star molecules for bioapplications |
| 12/23/1993 | CA2138038A1 Recombinant production of saporin-containing proteins |
| 12/23/1993 | CA2137829A1 Active component of parathyroid hypertensive factor |
| 12/23/1993 | CA2135397A1 T-cell membrane inducing factors |
| 12/23/1993 | CA2115668A1 Liquid phase synthesis of peptides and peptide derivatives |
| 12/22/1993 | EP0574575A1 Method for isolating biomolecules with linear polymers |
| 12/22/1993 | EP0574414A1 LIGAND GROWTH FACTORS THAT BIND TO THE erbB-2 RECEPTOR PROTEIN AND INDUCE CELLULAR RESPONSES |
| 12/22/1993 | CN1079825A Immunochemical detection of in vivo advanced glycosylation endproducts |
| 12/21/1993 | US5272266 Vinylsulphonylpristinamycin and its preparation |
| 12/21/1993 | US5272253 Cluster conjugates of drugs with antibodies |
| 12/21/1993 | US5272252 Synthetic lung surfactant having antioxidant properties |
| 12/21/1993 | US5272135 Method for the stabilization of methionine-containing polypeptides |
| 12/21/1993 | US5272075 System for solid phase reactions |
| 12/21/1993 | US5272066 Synthetic method for enhancing glycoprotein stability |
| 12/21/1993 | US5272063 Process of making human nerve growth factor |
| 12/18/1993 | CA2084136A1 Design, construction and expression of chimeric proteins for development of vaccines and diagnostic reagents |
| 12/15/1993 | EP0573611A1 Improved epitode displaying phage |
| 12/15/1993 | EP0573608A1 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
| 12/15/1993 | EP0573605A1 Preparation of factor ix |
| 12/15/1993 | EP0573603A1 Inhibitors of human neutrophil elastase and human cathepsin g |
| 12/15/1993 | EP0573599A1 Crystallizing biological macromolecules in microgravity. |
| 12/15/1993 | EP0573540A1 Process for the c-terminal modification of peptides having a c-terminal penultimate proline residue |
| 12/15/1993 | EP0573499A1 Process for the phosphorylation of insulin and product produced thereby. |
| 12/15/1993 | CA2074665A1 Process for labeling substances with technetium or rhenium |